Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?

Transarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference in peritoneal lesions with primary and recurrent tumors? The purpose of this article is to analyze the results of TACE in women with peritoneal lesions with primary and recurrent pelvis tumors. This is an analysis of 80 patients with primary tumors (group 1) and 20 patients with recurrent tumors of pelvis (group 2). 8 women in group 1 and 11 women in group 2 had an implantation lesion of peritoneum near the main focus, 3 women in group 1 and 4 women in group 2 had a peritoneum lesion at a distance from the main focus. Angiography revealed differences in blood supply of implantation metastases in the group of primary and recurrent tumors, as well as the blood supply of distant peritoneal metastases. These facts should be taken into account in order to reduce the number of errors in assessing the effectiveness of therapy, to obtain a good clinical result, and to avoid discrediting TACE due to unreasonable requirements for it. 

1. Senchik K.Yu., Bespalov V.G., Stukov A.N. Chemoperfusion treatment of peritoneal carcinomatosis. Vestnik Rossijskoy voenno-medicinskoy akademii = Bulletin of the Russian Military Medical Academy 2013;4(44):222–8. (In Russ.).

2. Loning М., Chan J.K., Monk B.J. et al. Peritoneal carcinomatosis. Surg 2004;1:27–38.

3. Cho J., Kim S. Peritoneal carcinomatosis and its mimics: review of CT findings for differential diagnosis. J Belgian Society Radiology 2020;104(1):8. DOI: 10.5334/jbsr.1940.

4. Castro-Mestaa J.F., González-Guerreroa J.F., Barrios-Sánchezb P., Villarreal-Cavazosa G. Bases and foundations of the treatment of peritoneal carcinomatosis: Review article. Medicina Universitaria 2016;18(71):98–104.

5. Cancer of the cervix. Clinical guidelines 2020. (In Russ.).

6. Cancer of the body of the uterus and uterine sarcomas. Clinical guidelines 2021. (In Russ.).

7. NCCN. Cervical Cancer. Version 1.2021. 8. Bhatla N., Aoki D., Sharma D. et al. Cancer of the cervix uteri: 2021 update. FIGO Cancer Report 2021. DOI: 10.1002/ijgo.13865.

8. Koskas M., Amant F., Mirza M. et al. Cancer of the corpus uteri: 2021 update. FIGO Cancer Report 2021. DOI: 10.1002/ijgo.13866.

9. Berek J.S., Renz M., Kehoe S. et al. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. FIGO Cancer Report 2021. DOI: 10.1002/ijgo.13878.

10. Abu-Rustum N., Yashar C., Bradley K. et al. NCCN Guidelines Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw 2021;19(8):888–95. DOI: 10.6004/jnccn.2021.0038.

11. Panagiotopoulou Р., Courcoutsakis N., Tentes A., Prassopoulos P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights Imaging 2021;12(1):168. DOI: 10.1186/s13244-021-01110-6.

12. Stepanov I.V., Paderov Yu.M., Afanasyev S.G. Peritoneal carcinomatosis. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2014;(5):45–53. (In Russ.).

13. Kosenko I.A., Matylevich O.P., Dudarev V.S. Efficiency of complex treatment of locally advanced cervical cancer using uterine artery chemoembolization. Onkologiya. Zhurnal im. P.A. Gercena = Oncology. P.A. Herzen Journal 2012;1(1):15–9. (In Russ.).

14. Kedrova A.G., Lebedev D.P., Astakhov D.A. The use of hepaspheres for chemoembolization of malignant tumors of the small pelvis as a stage of complex treatment. Opukholi zhenskoy reproduktivnoy systemy = Tumors of female reproductive system 2018;14(4):35–42. (In Russ.).

15. Wáng Y.J., De Baere T., Idée J.-M., Ballet S. Transcatheter embolization therapy in liver cancer: an update of clinical evidences. Chin J Cancer Res 2015;27(2): 96–121. DOI: 10.3978/j.issn.1000-9604. 2015.03.03.

16. Kennoki N., Saguchi T., Sano T. et al. Long-term histopathologic follow-up of a spherical embolic agent; observation of the transvascular migration of HepaSphere TM. BJR Case Rep 2019;5(1): 20180066. DOI: 10.1259/bjrcr.20180066.

17. Fedorko M.E., Hirsch J.G. Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum (I. Morphologiec aspects). Exp Cell Res 1971;69:113–27.

18. Flessner M.F. The importance of the interstitium in peritoneal transport. Perit Dial Int 1996;16:76–9.

19. Solomennyi S.V., Gantsev K.Sh., Kzyrgalin Sh.R., Minigazimov R.S. Anatomical prerequisites for the development and features of the course of peritoneal carcinomatosis. Ul’yanovskiy mediko-biologicheskiy zhurnal = Ulyanovsk biomedical journal 2016;(3):91. (In Russ.).